Fischer Imaging Looking To File SenoScan 510(k) In Second Quarter
This article was originally published in The Gray Sheet
Fischer Imaging expects to compile data from a 500-patient SenoScan clinical study by April 1 and submit a 510(k) application for the full-field digital mammography system later in the quarter, according to the company.
You may also be interested in...
Organizations like BARDA, CEPI and others are looking to partner with industry to rapidly test, manufacture, package and deploy vaccines and therapeutics, identifying areas they want to work together during BIO’s recent summit.
The economic stress on payers caused by the pandemic will cause a setback in the development of payment approaches for regenerative therapy, Blue Cross Blue Shield executive warns.
An interim final rule posted by the CMS this week widens further a series of telehealth exemptions and lab specimen collection payment provisions it has previously issued to help providers during the COVID-19 pandemic.